Potential of register-based studies to investigate rare diseases: Example of the first German population-based amyotrophic lateral sclerosis registry;Möglichkeiten register-basierter Studien zur Erforschung seltener Erkrankungen: Beispiel des ersten deutschen bevölkerungsbezogenen Registers für die Amyotrophe Lateralsklerose

Aktuelle Neurologie

Volumn 39, Issue 1, 2012, Pages 12-17

  Nagel, G ^a   Rosenbohm, A ^b   Unal H ^a   Rothenbacher, D ^a   Ludolph, A C ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

ALS; rare diseases; registry

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; GERMANY; HEAD INJURY; HUMAN; METABOLIC DISORDER; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POPULATION RESEARCH; REGISTER; RISK FACTOR; SPORT; TREATMENT PLANNING;

EID: 84856768932     PISSN: 03024350     EISSN: 14389428     Source Type: Journal    
DOI: 10.1055/s-0031-1301340     Document Type: Article

References (22)

1. Rückinger S, Boneberger A. Epidemiologic challenges in rare diseases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2008; 51 483 490
2. Aym S, Schmidtke J. Networking for rare diseases: a necessity for Europe. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2007; 50 1477 1483
3. Pommerening K, Debling D, Kaatsch P, Blettner M. Registries for rare diseases. Compliance and data protection. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz: 2008; 51 491 499
4. Brooks B R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosiso" workshop contributors. J Neurol Sci: 1994; 124 01 96 107
5. Heinemann L, Sinnecker H. Epidemiologische Arbeitsmethoden. Jena S. Fischer Verlag: 1994
6. Gliklich R E, Dreyer N. Registries for Evaluating Patient Outcomes: A Users Guide [Internet]. 2010 Sep [cited 2011 May 24];Available from: http://www.ncbi.nlm.nih.gov/books/NBK49444/
7. Nagel G, Zoller D, Wiedmann T et al. The use of the Epidemiology Cancer registry Baden-Württemberg in the follow-up of the EPIC cohort. Gesundheitswesen: 2004; 66 469 474 (Pubitemid 39279255)
8. Röhrig B, du Prel J-B, Wachtlin D et al. Types of study in medical research: part 3 of a series on evaluation of scientific publications. Dtsch Arztebl Int: 2009; 106 262 268
9. Gastl R, Ludolph A C. Amyotrophic lateral sclerosis. Nervenarzt: 2007; 78 1449 1457
10. Kiernan M C, Vucic S, Cheah B C et al. Amyotrophic lateral sclerosis. Lancet: 2011; 377 942 955
11. Lul D, Häcker S, Ludolph A et al. Depression and quality of life in patients with amyotrophic lateral sclerosis. Dtsch Arztebl Int: 2008; 105 397 403
12. Ludolph A C. Motor neuron disease: urgently needed-biomarkers for amyotrophic lateral sclerosis. Nat Rev Neurol: 2011; 7 13 14
13. nd Consensus Conference participants. Amyotroph. Lateral Scler. Other Motor Neuron Disord: 2000; 1 01 S79 S81
14. Logroscino G, Traynor B J, Hardiman O et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatr: 2010; 81 385 390
15. Beghi E, Logroscino G, Chi A et al. The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta: 2006; 1762 1150 1157 (Pubitemid 44750581)
16. Wang H, OReilly J, Weisskopf M G et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol: 2011; 68 207 213
17. Dupuis L, Corcia P, Fergani A et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology: 2008; 70 1004 1009 (Pubitemid 351451324)
18. Dorst J, Kühnlein P, Hendrich C et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol: 2011; 258 613 617
19. Fang L, Teuchert M, Huber-Abel F et al. MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS. J Neurol Sci: 2010; 294 51 56
20. Ludolph A C, Langen K J, Regard M et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand: 1992; 85 81 89
21. Mackenzie I R, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol: 2010; 9 995 1007
22. Hentschel S, Katalinic A. Das Manual der epidemiologischen Krebsregistrierung. München W. Zuckschwerdt Verlag: 2008